Pharma

Your Article Summary

See Latest Articles

Covidien Announces Highlights from Investor Meeting
Covidien, 09/11/09

Covidien, a leading global provider of healthcare products, held a meeting for the investment community today where it highlighted the strengths, strategies and innovations that are expected to drive the Company's growth in 2010 and beyond. In addition, the meeting included two interactive physician panels discussing the latest developments in several of the Company's key product lines.

Today in Conferences/Meetings...keeping you current

Receive free subspecialty "5-minute updates" via email

Repligen Announces Conference Call to Discuss Phase 3 Clinical Trial Results of RG1068 in MRI Imaging of the Pancreas Wednesday, December 9
Repligen, 12/09/09

Allos Therapeutics' FOLOTYN Demonstrates Activity in Patients with Relapsed or Refractory Peripheral T-Cell Lymphoma Treated with Stem Cell Transplant
Allos Therapeutics, 12/08/09

ARIAD Presents Positive Clinical Proof-of-Concept Data on AP24534 in Drug-Resistant Hematological Cancers at ASH Annual Meeting
ARIAD Pharmaceuticals, 12/08/09

 See all of Conferences/Meetings